Resource: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate
Source: U.S. Food and Drug Administration
Synopsis: The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
Comment: There are currently two vaccines which are being released for the vaccination of COVID-19 infection. One is the vaccine from Pfizer who is working with BioNTech, a company from Europe. The other is the Moderna vaccine. Both companies are seeking emergency use authorization. A meeting to discuss the emergency use authorization of these vaccines is scheduled for December 10, 2020.
